Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015.

Conclusions: The burden of MDR TB in children in the EU/EEA appears low, but may be underestimated owing to challenges in laboratory confirmation. Diagnostic improvements are needed for early detection and adequate treatment of MDR TB. Children previously treated for TB or of foreign origin may warrant higher attention. PMID: 29183553 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29183553?dopt=Abstract

Source: Euro Surveill - November 1, 2017 Category: Infectious Diseases Authors: Ködmön C, van den Boom M, Zucs P, van der Werf MJ Tags: Euro Surveill Source Type: research